Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239

Vaccine

Volumn 24, Issue 21, 2006, Pages 4498-4502

  Boyer, Jean D ^a   Maciag, Paulo C ^b   Parkinson, Rose ^a   Wu, Ling ^a   Lewis, Mark G ^c   Weiner, David B ^a   Paterson, Yvonne ^b  

^a Stellar Chance Laboratories   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

DNA vaccine; HIV SIV vaccine; Listeria monocytogenes; Prime boost

Indexed keywords

BACTERIAL VACCINE; DNA VACCINE; GAMMA INTERFERON; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CELL SECRETION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; IMMUNE RESPONSE; IMMUNE STATUS; LISTERIA MONOCYTOGENES; MACACA; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS LOAD;

ANIMALS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERFERON-GAMMA; MACACA MULATTA; MALE; RNA, VIRAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD; VIRAL VACCINES;

EID: 33646840310     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.016     Document Type: Article

References (16)

1. Shiver J.W., Perry H.C., Davies M.E., Freed D.C., and Liu M.A. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination. Ann NY Acad Sci 772 (1995) 198-208
2. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283 5403 (1999) 857-860
3. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292 5514 (2001) 69-74
4. Barouch D.H., Santra S., Kuroda M.J., Schmitz J.E., Plishka R., Buckler-White A., et al. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. J Virol 75 11 (2001) 5151-5158
5. Shiver J. A non-replicating adenoviral vector as a potential HIV vaccine. Res Initiat Treat Action 8 2 (2003) 14-16
6. Van Loon F.P., Clemens J.D., Chakraborty J., Rao M.R., Kay B.A., Sack D.A., et al. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine 14 2 (1996) 162-166
7. Seth A., Ourmanov I., Kuroda M.J., Schmitz J.E., Carroll M.W., Wyatt L.S., et al. Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer. Proc Natl Acad Sci USA 95 17 (1998) 10112-10116
8. Seth A., Ourmanov I., Schmitz J.E., Kuroda M.J., Lifton M.A., Nickerson C.E., et al. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge. J Virol 74 6 (2000) 2502-2509
9. Rose N.F., Marx P.A., Luckay A., Nixon D.F., Moretto W.J., Donahoe S.M., et al. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106 5 (2001) 539-549
10. Vajdy M., Gardner J., Neidleman J., Cuadra L., Greer C., Perri S., et al. Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles. J Infect Dis 184 12 (2001) 1613-1616
11. Worku S., Gorse G.J., Belshe R.B., and Hoft D.F. Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production. J Infect Dis 184 5 (2001) 525-532
12. Marsac D., Loirat D., Petit C., Schwartz O., and Michel M.L. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles. J Virol 76 15 (2002) 7544-7553
13. Hanke T., Samuel R.V., Blanchard T.J., Neumann V.C., Allen T.M., Boyson J.E., et al. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J Virol 73 9 (1999) 7524-7532
14. Allen T.M., Vogel T.U., Fuller D.H., Mothe B.R., Steffen S., Boyson J.E., et al. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J Immunol 164 9 (2000) 4968-4978
15. Boyer J.D., Robinson T.M., Maciag P.C., Peng X., Johnson R.S., Pavlakis G., et al. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology 333 1 (2005) 88-101
16. Suryanarayana K., Wiltrout T.A., Vasquez G.M., Hirsch V.M., and Lifson J.D. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 14 2 (1998) 183-189